• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

源自人诱导多能干细胞的免疫抑制性间充质基质细胞诱导人调节性T细胞以及……(原文此处不完整)

Immunosuppressive Mesenchymal Stromal Cells Derived from Human-Induced Pluripotent Stem Cells Induce Human Regulatory T Cells and .

作者信息

Roux Clémence, Saviane Gaëlle, Pini Jonathan, Belaïd Nourhène, Dhib Gihen, Voha Christine, Ibáñez Lidia, Boutin Antoine, Mazure Nathalie M, Wakkach Abdelilah, Blin-Wakkach Claudine, Rouleau Matthieu

机构信息

LP2M, CNRS-UMR 7370, Faculty of Medicine, Nice, France.

Université Nice-Sophia Antipolis, Nice, France.

出版信息

Front Immunol. 2018 Jan 25;8:1991. doi: 10.3389/fimmu.2017.01991. eCollection 2017.

DOI:10.3389/fimmu.2017.01991
PMID:29422893
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5788894/
Abstract

Despite mesenchymal stromal cells (MSCs) are considered as a promising source of cells to modulate immune functions on cells from innate and adaptive immune systems, their clinical use remains restricted (few number, limited expansion, absence of a full phenotypic characterization, few insights on their fate). Standardized MSCs derived from human-induced pluripotent stem (huIPS) cells, remediating part of these issues, are considered as well as a valuable tool for therapeutic approaches, but their functions remained to be fully characterized. We generated multipotent MSCs derived from huiPS cells (huiPS-MSCs), and focusing on their immunosuppressive activity, we showed that human T-cell activation in coculture with huiPS-MSCs was significantly reduced. We also observed the generation of functional CD4 FoxP3 regulatory T (Treg) cells. Further tested in a model of human T-cell expansion in immune-deficient NSG mice, huiPS-MSCs immunosuppressive activity prevented the circulation and the accumulation of activated human T cells. Intracytoplasmic labeling of cytokines produced by the recovered T cells showed reduced percentages of human-differentiated T cells producing Th1 inflammatory cytokines. By contrast, T cells producing IL-10 and FoxP3-Treg cells, absent in non-treated animals, were detected in huiPS-MSCs treated mice. For the first time, these results highlight the immunosuppressive activity of the huiPS-MSCs on human T-cell stimulation with a concomitant generation of human Treg cells . They may favor the development of new tools and strategies based on the use of huiPS cells and their derivatives for the induction of immune tolerance.

摘要

尽管间充质基质细胞(MSCs)被认为是调节先天性和适应性免疫系统细胞免疫功能的一种很有前景的细胞来源,但其临床应用仍然受到限制(数量少、扩增有限、缺乏完整的表型特征、对其命运了解甚少)。源自人诱导多能干细胞(huIPS)的标准化MSCs弥补了部分这些问题,被认为是治疗方法的一种有价值的工具,但其功能仍有待充分表征。我们从huIPS细胞中生成了多能MSCs(huiPS-MSCs),并专注于它们的免疫抑制活性,结果表明与huiPS-MSCs共培养时人T细胞的活化显著降低。我们还观察到功能性CD4 FoxP3调节性T(Treg)细胞的产生。在免疫缺陷NSG小鼠的人T细胞扩增模型中进一步测试发现,huiPS-MSCs的免疫抑制活性阻止了活化的人T细胞的循环和积累。对回收的T细胞产生的细胞因子进行胞内标记显示,产生Th1炎性细胞因子的人分化T细胞百分比降低。相比之下,在未处理动物中不存在的产生IL-10的T细胞和FoxP3-Treg细胞在huiPS-MSCs处理的小鼠中被检测到。这些结果首次突出了huiPS-MSCs对人T细胞刺激的免疫抑制活性,并伴随产生人Treg细胞。它们可能有利于基于huiPS细胞及其衍生物诱导免疫耐受的新工具和新策略的开发。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e083/5788894/d80495f8d516/fimmu-08-01991-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e083/5788894/8c39f110aa26/fimmu-08-01991-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e083/5788894/80c6b10d4f40/fimmu-08-01991-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e083/5788894/f8a0e8e421a7/fimmu-08-01991-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e083/5788894/a830f7191f2a/fimmu-08-01991-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e083/5788894/0bfec72e0ef9/fimmu-08-01991-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e083/5788894/d80495f8d516/fimmu-08-01991-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e083/5788894/8c39f110aa26/fimmu-08-01991-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e083/5788894/80c6b10d4f40/fimmu-08-01991-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e083/5788894/f8a0e8e421a7/fimmu-08-01991-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e083/5788894/a830f7191f2a/fimmu-08-01991-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e083/5788894/0bfec72e0ef9/fimmu-08-01991-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e083/5788894/d80495f8d516/fimmu-08-01991-g006.jpg

相似文献

1
Immunosuppressive Mesenchymal Stromal Cells Derived from Human-Induced Pluripotent Stem Cells Induce Human Regulatory T Cells and .源自人诱导多能干细胞的免疫抑制性间充质基质细胞诱导人调节性T细胞以及……(原文此处不完整)
Front Immunol. 2018 Jan 25;8:1991. doi: 10.3389/fimmu.2017.01991. eCollection 2017.
2
Bone marrow-derived mesenchymal stem cells favor the immunosuppressive T cells skewing in a Helicobacter pylori model of gastric cancer.骨髓间充质干细胞有利于在胃癌的幽门螺杆菌模型中偏向免疫抑制性 T 细胞。
Stem Cells Dev. 2013 Nov 1;22(21):2836-48. doi: 10.1089/scd.2013.0166. Epub 2013 Aug 16.
3
Combination cell therapy using mesenchymal stem cells and regulatory T-cells provides a synergistic immunomodulatory effect associated with reciprocal regulation of TH1/TH2 and th17/treg cells in a murine acute graft-versus-host disease model.在小鼠急性移植物抗宿主病模型中,使用间充质干细胞和调节性T细胞的联合细胞疗法可提供一种协同免疫调节作用,该作用与TH1/TH2和Th17/Treg细胞的相互调节相关。
Cell Transplant. 2014 Apr;23(6):703-14. doi: 10.3727/096368913X664577. Epub 2013 Feb 26.
4
Opposing effect of mesenchymal stem cells on Th1 and Th17 cell polarization according to the state of CD4+ T cell activation.根据 CD4+T 细胞激活状态,间充质干细胞对 Th1 和 Th17 细胞极化的相反作用。
Immunol Lett. 2011 Mar 30;135(1-2):10-6. doi: 10.1016/j.imlet.2010.09.006. Epub 2010 Oct 1.
5
The immunomodulatory effects of human mesenchymal stem cells on peripheral blood mononuclear cells in ALS patients.人骨髓间充质干细胞对肌萎缩侧索硬化症患者外周血单个核细胞的免疫调节作用。
J Neurochem. 2014 Oct;131(2):206-18. doi: 10.1111/jnc.12814. Epub 2014 Jul 31.
6
Treatment of experimental arthritis by inducing immune tolerance with human adipose-derived mesenchymal stem cells.用人脂肪间充质干细胞诱导免疫耐受治疗实验性关节炎
Arthritis Rheum. 2009 Apr;60(4):1006-19. doi: 10.1002/art.24405.
7
Mesenchymal Stem Cells Overexpressing Interleukin-35 Propagate Immunosuppressive Effects in Mice.过表达白细胞介素-35的间充质干细胞在小鼠中发挥免疫抑制作用。
Scand J Immunol. 2017 Nov;86(5):389-395. doi: 10.1111/sji.12613. Epub 2017 Oct 5.
8
IL-17 down-regulates the immunosuppressive capacity of olfactory ecto-mesenchymal stem cells in murine collagen-induced arthritis.白细胞介素-17下调小鼠胶原诱导性关节炎中嗅外间充质干细胞的免疫抑制能力。
Oncotarget. 2016 Jul 12;7(28):42953-42962. doi: 10.18632/oncotarget.10261.
9
In Vitro Generation of IL-35-expressing Human Wharton's Jelly-derived Mesenchymal Stem Cells Using Lentiviral Vector.利用慢病毒载体体外生成表达白细胞介素-35的人脐带华通氏胶间充质干细胞
Iran J Allergy Asthma Immunol. 2015 Aug;14(4):416-26.
10
Adipose tissue-derived mesenchymal stem cells induce expansion of interleukin-10-producing regulatory B cells and ameliorate autoimmunity in a murine model of systemic lupus erythematosus.脂肪组织来源的间充质干细胞可诱导产生白细胞介素-10的调节性B细胞扩增,并改善系统性红斑狼疮小鼠模型中的自身免疫反应。
Cell Transplant. 2015;24(11):2367-77. doi: 10.3727/096368914X685645. Epub 2014 Dec 12.

引用本文的文献

1
Mesenchymal stem/stromal cell therapy improves immune recovery in a feline model of severe coronavirus infection.间充质干/基质细胞疗法可改善严重冠状病毒感染猫模型的免疫恢复。
Stem Cells Transl Med. 2025 Jun 25;14(7). doi: 10.1093/stcltm/szaf025.
2
Induced pluripotent stem cell-derived mesenchymal stem cells (iMSCs) inhibit M1 macrophage polarization and reduce alveolar bone loss associated with periodontitis.诱导多能干细胞来源的间充质干细胞(iMSCs)可抑制M1巨噬细胞极化,并减少与牙周炎相关的牙槽骨丧失。
Stem Cell Res Ther. 2025 May 2;16(1):223. doi: 10.1186/s13287-025-04327-0.
3
Role of mesenchymal stem cells in sepsis and their therapeutic potential in sepsis‑associated myopathy (Review).

本文引用的文献

1
The Immunogenicity and Immune Tolerance of Pluripotent Stem Cell Derivatives.多能干细胞衍生物的免疫原性和免疫耐受性
Front Immunol. 2017 Jun 2;8:645. doi: 10.3389/fimmu.2017.00645. eCollection 2017.
2
Helios Should Not Be Cited as a Marker of Human Thymus-Derived Tregs. Commentary: Helios(+) and Helios(-) Cells Coexist within the Natural FOXP3(+) T Regulatory Cell Subset in Humans.不应将Helios作为人类胸腺来源调节性T细胞的标志物。评论:Helios阳性和Helios阴性细胞共存于人类天然FOXP3阳性调节性T细胞亚群中。
Front Immunol. 2016 Jul 8;7:276. doi: 10.3389/fimmu.2016.00276. eCollection 2016.
3
Inhibition of IKK/NF-κB Signaling Enhances Differentiation of Mesenchymal Stromal Cells from Human Embryonic Stem Cells.
间充质干细胞在脓毒症中的作用及其在脓毒症相关性肌病中的治疗潜力(综述)。
Int J Mol Med. 2024 Nov;54(5). doi: 10.3892/ijmm.2024.5416. Epub 2024 Sep 2.
4
Multipotent Mesenchymal Stem Cell-Based Therapies for Spinal Cord Injury: Current Progress and Future Prospects.基于多能间充质干细胞的脊髓损伤治疗:当前进展与未来展望
Biology (Basel). 2023 Apr 26;12(5):653. doi: 10.3390/biology12050653.
5
Aging and Mesenchymal Stem Cells: Basic Concepts, Challenges and Strategies.衰老与间充质干细胞:基本概念、挑战与策略
Biology (Basel). 2022 Nov 18;11(11):1678. doi: 10.3390/biology11111678.
6
Translating MSC Therapy in the Age of Obesity.肥胖时代的间充质干细胞治疗。
Front Immunol. 2022 Jul 4;13:943333. doi: 10.3389/fimmu.2022.943333. eCollection 2022.
7
TA-MSCs, TA-MSCs-EVs, MIF: their crosstalk in immunosuppressive tumor microenvironment.TA-MSCs、TA-MSCs-EVs、MIF:它们在免疫抑制性肿瘤微环境中的相互作用。
J Transl Med. 2022 Jul 16;20(1):320. doi: 10.1186/s12967-022-03528-y.
8
A Brief Overview of Global Trends in MSC-Based Cell Therapy.间充质干细胞(MSC)为基础的细胞治疗的全球趋势简述
Stem Cell Rev Rep. 2022 Jun;18(5):1525-1545. doi: 10.1007/s12015-022-10369-1. Epub 2022 Mar 28.
9
Humanized Mice as a Valuable Pre-Clinical Model for Cancer Immunotherapy Research.人源化小鼠作为癌症免疫治疗研究的重要临床前模型。
Front Oncol. 2021 Nov 18;11:784947. doi: 10.3389/fonc.2021.784947. eCollection 2021.
10
Mesenchymal Stem Cell Transplantation for the Treatment of Age-Related Musculoskeletal Frailty.间质干细胞移植治疗与年龄相关的肌肉骨骼虚弱。
Int J Mol Sci. 2021 Sep 29;22(19):10542. doi: 10.3390/ijms221910542.
抑制 IKK/NF-κB 信号通路增强人胚胎干细胞来源间充质基质细胞的分化。
Stem Cell Reports. 2016 Apr 12;6(4):456-465. doi: 10.1016/j.stemcr.2016.02.006. Epub 2016 Mar 10.
4
Co-transplantation of multipotent mesenchymal stromal cells in allogeneic hematopoietic stem cell transplantation: A systematic review and meta-analysis.多能间充质基质细胞在异基因造血干细胞移植中的联合移植:一项系统评价和荟萃分析。
Cytotherapy. 2016 Feb;18(2):172-85. doi: 10.1016/j.jcyt.2015.11.010.
5
Mesenchymal stem cells and immunomodulation: current status and future prospects.间充质干细胞与免疫调节:现状与展望。
Cell Death Dis. 2016 Jan 21;7(1):e2062. doi: 10.1038/cddis.2015.327.
6
Modeling Andersen's Syndrome in Human Induced Pluripotent Stem Cells.在人类诱导多能干细胞中模拟安德森综合征
Stem Cells Dev. 2016 Jan 15;25(2):151-9. doi: 10.1089/scd.2015.0258. Epub 2015 Dec 30.
7
Immune modulatory mesenchymal stem cells derived from human embryonic stem cells through a trophoblast-like stage.通过滋养层样阶段从人胚胎干细胞衍生而来的免疫调节间充质干细胞。
Stem Cells. 2016 Feb;34(2):380-91. doi: 10.1002/stem.2242. Epub 2015 Nov 28.
8
Differences in Expression Level of Helios and Neuropilin-1 Do Not Distinguish Thymus-Derived from Extrathymically-Induced CD4+Foxp3+ Regulatory T Cells.Helios和神经纤毛蛋白-1表达水平的差异无法区分胸腺来源与胸腺外诱导的CD4+Foxp3+调节性T细胞。
PLoS One. 2015 Oct 23;10(10):e0141161. doi: 10.1371/journal.pone.0141161. eCollection 2015.
9
iPSC-MSCs Combined with Low-Dose Rapamycin Induced Islet Allograft Tolerance Through Suppressing Th1 and Enhancing Regulatory T-Cell Differentiation.诱导多能干细胞来源的间充质干细胞联合低剂量雷帕霉素通过抑制Th1和增强调节性T细胞分化诱导胰岛移植耐受
Stem Cells Dev. 2015 Aug 1;24(15):1793-804. doi: 10.1089/scd.2014.0488. Epub 2015 May 18.
10
Biomarker profiling of steroid-resistant acute GVHD in patients after infusion of mesenchymal stromal cells.输注间充质基质细胞后类固醇耐药性急性移植物抗宿主病患者的生物标志物分析。
Leukemia. 2015 Sep;29(9):1839-46. doi: 10.1038/leu.2015.89. Epub 2015 Apr 3.